Glycemic Control and the Brain in Children With Type 1 Diabetes
Trial ID or NCT#
NCT03428932
Status
RECRUITING
Purpose
The purpose of this study is to determine if improving diabetes control by better controlling blood sugars, will help improve or normalize brain function as compared to routine diabetes care. We will use either the patient's own insulin routine (injections or insulin pumps) or a closed-loop insulin pump (Medtronic 670G). This system uses a continuous glucose monitor (CGM) and an insulin pump to automatically give insulin and may improve control of blood sugars.
Official Title
Glycemic Control and the Brain in Children With Type 1 Diabetes
Eligibility Criteria
Ages Eligible for Study: 14 Years to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Be at least 14 and not yet 18 years old - Must have been diagnosed with T1D prior to 5 years old but after 6 months - For those diagnosed prior to 1 year of age, a positive blood test for an antibody marker will be required - Have been born term or near term (≥34 weeks) and weighed more than≥ 2 kg (4.4lbs) at birth - Be in puberty
Exclusion Criteria:
- - History of intellectual disability, language or learning disability identified before diagnosis of diabetes, or enrollment in a self-contained special education program - ADD/ADHD and/or on stimulant medication - Any known genetic or medical problem that could impair brain development - Abnormalities of the brain/nervous system, visual or hearing problem - History of seizures not associated with fever before diabetes diagnosis - Previous inpatient psychiatric treatment - Unable to have a MRI of the head due to having metal: including metal ear tubes, full set of braces in mouth (retainer is acceptable), other appliances, or vascular clip
Investigator(s)
Tandy Aye
Darrell Wilson
Contact us to find out if this trial is right for you.
Contact
Tali Jacobson
650-721-8782
View on ClinicalTrials.gov
